[When will the nicotine vaccine be ready?].
نویسنده
چکیده
منابع مشابه
The Adverse Effects of Nicotine and Carbon Monoxide on Cardiovascular Disease
Cigarette smoking causes injury of coronary arteries as well as other arteries. Sudden death is more frequent in heavy smokers than in non smokers. Studies showed that dangerous arrhythmias will be the result of effect of nicotine when injected in the animals. Carbon-monooxide is also dangerous for man when it is produced by smoking. The prevention of heart disease will be more satisfactory ...
متن کاملStrategies of vaccine production against COVID-19: when will an effective vaccine be produced?
There is a strong consensus globally that production of an effective vaccine against SARS-CoV-2 is likely the most effective approach to sustainably controlling the COVID-19 pandemic. An unprecedented research effort and global coordination has resulted in a rapid development of vaccine candidates and initiation of trials. In this paper, we review vaccine candidate against COVID-19 and also cha...
متن کاملIs a vaccine one of the factors that will contribute to the end of the Pandemic?
The covid-19 pandemic began in China in November 2019 and spread globally by March 2020.[2] In India Vaccine research, trials, and production were ramped up gradually. The Covishield vaccine trial was completed by December 2020 and the mass vaccination program started in January 2021. The mortality was far more in western and European countries (despite better health infrastructure) than in Asi...
متن کاملنظارت و کنترل سازمانی از دیدگاه اسلام
Control and check in one of the basic elements of management. Without regard to control and check, the other elements of management, such as planning, organizing, and guidance will suffer severely, and there will not be any guarantee for the right implementation of them. In fact, when a plan is prepared, when it is organized and when it is ready to be implemented, we expect that the objectives ...
متن کاملThe efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
BACKGROUND A potential new treatment in smoking cessation and relapse prevention is nicotine vaccination which is based on active immunization against the nicotine molecule. This immunization will elicit the immune system to produce nicotine-specific antibodies that sequester nicotine in the blood stream, after inhaling tobacco products. The resulting antibody-antigen is too large to cross the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Archivos de bronconeumologia
دوره 41 1 شماره
صفحات -
تاریخ انتشار 2005